Full article view 2017-09-21T12:14:01+00:00
Back to News & Insights »

David Parker Discusses CDx Development in Clinical OMICs

 

David Parker, SVP, Diagnostics Solutions, was interviewed along with a panel of experts on changes in CDx development in Clinical Omics. Click here to read the complete article.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.